Srphc82281225-coronary Drug Eluting Stents With (1) Cobalt Chromium Alloy (2) Coating Of Bioabsorbable Polymer Carrier With Abluminal And Gradient Coating Foractive Drug Shown To Be Effective In Preventing Neo-intimal Hyperplasia) (3) Stent Diameter Should Be From 2.5mm To 4mm . The Length Of The Stent Should Be From 12mm To 38 Mm. (4) The Strut Thickness Should Be 91 Micron Or Less. (5) Stent Delivery System Should Bemonorail (single Operator Exchange Or Rapid Exchange). (6) Stent Should Be Compatible With 5fr Guiding Catheter (7) Stent Design Should Be Open Cell Type. (8) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid. (9) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-stent Restenosis (isr) And In-situ Thrombosis (ist) Should Be Documented / Published In Peer Reviewed Scientific Journals. (10) Safety Of Abbreviated (one Month) Dual Antiplatelet Therapy For High Bleedingrisk Patients Should Be Documented In Peer Reviewed Journals. (11) The Manufacturer/supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute. Bis Standards For The Drug Eluting Stent Are Not Available. (reference:bis Catalogue ).[quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total Po Value Variation Permitted: Max 8 Lacs ] Delivery/work location: , Tamil Nadu. This is a Open tender. Bid closing date: 16-06-2026.

Detailed eligibility criteria are available in the tender document.
Download document →